11,716 Shares in UiPath Inc. (NYSE:PATH) Bought by Panagora Asset Management Inc.

Panagora Asset Management Inc. purchased a new stake in UiPath Inc. (NYSE:PATH) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 11,716 shares of the healthcare company’s stock, valued at approximately $291,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Inflection Point Investments LLP bought a new position in shares of UiPath during the 4th quarter worth approximately $10,255,000. Beacon Pointe Advisors LLC bought a new position in shares of UiPath in the fourth quarter valued at about $556,000. Janney Montgomery Scott LLC acquired a new stake in shares of UiPath during the 4th quarter worth about $1,744,000. Vanguard Personalized Indexing Management LLC boosted its holdings in shares of UiPath by 3.3% during the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 45,954 shares of the healthcare company’s stock worth $1,141,000 after buying an additional 1,458 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in UiPath by 27.8% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 170,409 shares of the healthcare company’s stock valued at $4,233,000 after acquiring an additional 37,103 shares during the period. Institutional investors own 62.50% of the company’s stock.

Insider Activity

In related news, CFO Ashim Gupta sold 40,000 shares of the company’s stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $21.66, for a total transaction of $866,400.00. Following the completion of the transaction, the chief financial officer now directly owns 660,762 shares in the company, valued at approximately $14,312,104.92. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In the last three months, insiders have sold 96,000 shares of company stock worth $2,023,440. Corporate insiders own 22.37% of the company’s stock.

UiPath Stock Performance

NYSE PATH opened at $18.98 on Friday. The business has a fifty day moving average price of $20.63 and a two-hundred day moving average price of $22.10. UiPath Inc. has a fifty-two week low of $13.30 and a fifty-two week high of $27.87.

UiPath (NYSE:PATH) last announced its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The business had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. As a group, research analysts predict that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on PATH. Royal Bank of Canada restated a “sector perform” rating and set a $29.00 price objective on shares of UiPath in a report on Monday, April 1st. Truist Financial reaffirmed a “buy” rating and issued a $32.00 price objective on shares of UiPath in a report on Wednesday, March 20th. Barclays boosted their target price on shares of UiPath from $23.00 to $25.00 and gave the company an “equal weight” rating in a research report on Friday, March 15th. KeyCorp initiated coverage on shares of UiPath in a research report on Monday, April 8th. They set an “overweight” rating and a $27.00 price target on the stock. Finally, TD Cowen lifted their price objective on shares of UiPath from $25.00 to $28.00 and gave the stock an “outperform” rating in a research note on Thursday, March 14th. Nine equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, UiPath has an average rating of “Moderate Buy” and a consensus target price of $27.41.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.